Trials / Conditions / Haemophilus Influenzae Type B Infection

Haemophilus Influenzae Type B Infection

16 registered clinical trials studyying Haemophilus Influenzae Type B Infection — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugat NCT07203755	CanSino Biologics Inc.	Phase 1
Active Not Recruiting	Clinical Trial of Lyophilized Haemophilus Influenzae Type b Conjugate Vaccine NCT06621654	CanSino Biologics Inc.	Phase 1
Not Yet Recruiting	Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healt NCT06618196	LG Chem	Phase 2
Recruiting	Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants NCT06605755	Jiangsu Province Centers for Disease Control and Prevention	N/A
Unknown	A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults NCT05952596	LG Chem	Phase 1
Unknown	Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Prima NCT05457946	LG Chem	Phase 2 / Phase 3
Completed	Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the Hib NCT04978818	Johns Hopkins Bloomberg School of Public Health	Phase 4
Unknown	Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants NCT04073459	LG Chem	Phase 2
Unknown	A Phase IV Study to Assess the Safety of EupentaTM Inj NCT04056728	LG Chem	Phase 4
Completed	Evaluation of an Infant Immunization Encouragement Program in Nigeria NCT03870061	GiveWell	N/A
Unknown	Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan NCT03341195	Aga Khan University	N/A
Completed	A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults NCT03208101	LG Chem	Phase 1
Completed	Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda NCT04177485	Centers for Disease Control and Prevention	N/A
Completed	DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed NCT02094833	Sanofi Pasteur, a Sanofi Company	Phase 3
Completed	Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children NCT01404962	Novartis Vaccines	Phase 4
Completed	Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infan NCT00654901	Sanofi Pasteur, a Sanofi Company	Phase 3